MedMesh.i
Checkpoint
PubMed
Racine
Checkpoint
PubMed
Exploration
Accueil
Racine
Racine

Serveur d'exploration Tocilizumab - Checkpoint (PubMed)

Index « MedMesh.i » - entrée « Retreatment »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Retinal Neoplasms < Retreatment < Retroperitoneal Fibrosis  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 18.
Ident.Authors (with country if any)Title
000254 (2019) Bartlomiej Wawrzycki [Pologne] ; Dorota Krasowska [Pologne] ; Aldona Pietrzak [Pologne] ; Ewa Wielosz [Pologne] ; Maria Majdan [Pologne] ; Torello Lotti [Italie]Urticarial rash, fever, and arthritis: A case of refractory Adult-onset Still's disease with good response to tocilizumab.
000525 (2019) Héctor Corominas ; Cayetano Alegre ; Javier Narváez [Espagne] ; Carlos Marras Fernández-Cid ; Vicenç Torrente-Segarra ; Manuel Rodríguez G Mez ; Francisco Maceiras Pan ; Rosa María Morlà ; Fernando José Rodríguez Martínez ; Antoni G Mez-Centeno [Espagne] ; Laura Losada Ares ; Rocío González Molina ; Silvia Paredes González-Albo ; Joan Dalmau-Carolà ; Carolina Pérez-García [Espagne] ; Ceferino Barbazán Álvarez ; Liliana Ercole [Espagne] ; Maria Ngeles Terrancle [Espagne]Correlation of fatigue with other disease related and psychosocial factors in patients with rheumatoid arthritis treated with tocilizumab: ACT-AXIS study.
000647 (2018) Mathilde Leclercq [France] ; M. Le Besnerais [France] ; V. Langlois [France] ; N. Girszyn [France] ; Y. Benhamou [France] ; C. Ngo [France] ; H. Levesque [France] ; M. Muraine [France] ; J. Gueudry [France]Tocilizumab for the treatment of birdshot uveitis that failed interferon alpha and anti-tumor necrosis factor-alpha therapy: two cases report and literature review.
000A66 (2017) Fabrizio Cantini [Italie] ; Laura Niccoli [Italie] ; Carlotta Nannini [Italie] ; Emanuele Cassarà [Italie] ; Olga Kaloudi [Italie] ; Ennio Giulio Favalli [Italie] ; Andrea Becciolini [Italie] ; Maurizio Benucci [Italie] ; Francesca Li Gobbi [Italie] ; Serena Guiducci [Italie] ; Rosario Foti [Italie] ; Marta Mosca [Italie] ; Delia Goletti [Italie]Second-line biologic therapy optimization in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis.
000B70 (2017) Hiroaki Matsuno [Japon] ; Kou Katayama [Japon]Effectiveness of golimumab for rheumatoid arthritis in patients with an inadequate response to tocilizumab.
000D99 (2016) Toshihiko Komai [Japon] ; Hirofumi Shoda [Japon] ; Kenichi Yamaguchi [Japon] ; Keiichi Sakurai [Japon] ; Mihoko Shibuya [Japon] ; Kanae Kubo [Japon] ; Toshiyuki Takahashi [Japon] ; Keishi Fujio [Japon] ; Kazuhiko Yamamoto [Japon]Neuromyelitis optica spectrum disorder complicated with Sjogren syndrome successfully treated with tocilizumab: A case report.
000E43 (2016) Shunsuke Mori [Japon] ; Yukinori Koga [Japon]Glucocorticoid-resistant polymyalgia rheumatica: pretreatment characteristics and tocilizumab therapy.
000E51 (2016) Christoph Tappeiner [Pays-Bas] ; Marina Mesquida [Pays-Bas] ; Alfredo Adán [Pays-Bas] ; Jordi Anton [Pays-Bas] ; Athimalaipet V. Ramanan [Pays-Bas] ; Ester Carreno [Pays-Bas] ; Friederike Mackensen [Pays-Bas] ; Kaisu Kotaniemi [Pays-Bas] ; Joke H. De Boer [Pays-Bas] ; Rosa Bou [Pays-Bas] ; Carmen García De Vicu A [Pays-Bas] ; Arnd Heiligenhaus [Pays-Bas]Evidence for Tocilizumab as a Treatment Option in Refractory Uveitis Associated with Juvenile Idiopathic Arthritis.
000E94 (2016) Mitsuhiro Akiyama [Japon] ; Yuko Kaneko [Japon] ; Harumi Kondo [Japon] ; Tsutomu Takeuchi [Japon]Comparison of the clinical effectiveness of tumour necrosis factor inhibitors and abatacept after insufficient response to tocilizumab in patients with rheumatoid arthritis.
001154 (2015) Kostas Athanasakis [Grèce] ; Filippos Tarantilis ; Konstantina Tsalapati ; Thomais Konstantopoulou ; Eleni Vritzali ; John KyriopoulosCost-utility analysis of tocilizumab monotherapy in first line versus standard of care for the treatment of rheumatoid arthritis in Greece.
001208 (2015) Surabhi Waghmare ; Bernardas Valecka ; Andrew P. CairnsA SEVERE CASE OF ADULT ONSET STILLS DISEASE WITH MYOPERICARDITIS, RESISTANT TO TREATMENT WITH TOCILIZUMAB BUT RESPONSIVE TO ANAKINRA.
001295 (2014) Norihiro Nishimoto [Japon] ; Koichi Amano ; Yasuhiko Hirabayashi ; Takahiko Horiuchi ; Tomonori Ishii ; Mitsuhiro Iwahashi ; Masahiro Iwamoto ; Hitoshi Kohsaka ; Masakazu Kondo ; Tsukasa Matsubara ; Toshihide Mimura ; Hisaaki Miyahara ; Shuji Ohta ; Yukihiko Saeki ; Kazuyoshi Saito ; Hajime Sano ; Kiyoshi Takasugi ; Tsutomu Takeuchi ; Shigeto Tohma ; Tomomi Tsuru ; Yukitaka Ueki ; Jiro Yamana ; Jun Hashimoto ; Takaji Matsutani ; Miho Murakami ; Nobuhiro TakagiRetreatment efficacy and safety of tocilizumab in patients with rheumatoid arthritis in recurrence (RESTORE) study.
001376 (2014) Yoshiya Tanaka [Japon] ; Tsutomu Takeuchi ; Koichi Amano ; Kazuyoshi Saito ; Kentaro Hanami ; Masao Nawata ; Shunsuke Fukuyo ; Hideto Kameda ; Yuko Kaneko ; Takahiko Kurasawa ; Hayato Nagasawa ; Daisuke Hoshi ; Eri Sato ; Hisashi YamanakaEffect of interleukin-6 receptor inhibitor, tocilizumab, in preventing joint destruction in patients with rheumatoid arthritis showing inadequate response to TNF inhibitors.
001490 (2013) Takeshi Suzuki [Japon] ; Masanobu Horikoshi ; Makoto Sugihara ; Tomoya Hirota ; Hiroshi Ogishima ; Naoto Umeda ; Yuya Kondo ; Hiroto Tsuboi ; Taichi Hayashi ; Yusuke Chino ; Isao Matsumoto ; Takayuki SumidaTherapeutic efficacy of tocilizumab in patients with rheumatoid arthritis refractory to anti-tumor-necrosis-factor inhibitors: 1 year follow-up with low-field extremity MRI.
001529 (2013) Zachary S. Wallace ; John H. StoneRefractory relapsing polychondritis treated with serial success with interleukin 6 receptor blockade.
001720 (2012) Hiroki Wakabayashi [Japon] ; Akihiro Sudo ; Yosuke Nishioka ; Masahiro Hasegawa ; Yukari Minami ; Kusuki NishiokaRepeat etanercept administration restores clinical response of patients with rheumatoid arthritis.
001805 (2012) Shunsuke MoriAdditional use of tacrolimus after switching to tocilizumab therapy in patients with primary lack of efficacy of infliximab therapy for rheumatoid arthritis.
001847 (2011) Akira Sagawa [Japon]The efficacy and safety of reinstitution of tocilizumab in patients with relapsed active rheumatoid arthritis after long-term withdrawal of tocilizumab: retreatment of patients with rheumatoid arthritis with novel anti-IL-6 receptor antibody after a long-term interval following SAMURAI: the RONIN study.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/PubMed/Checkpoint

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/MedMesh.i -k "Retreatment" 

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/MedMesh.i  \
                -Sk "Retreatment" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    PubMed
   |étape=   Checkpoint
   |type=    indexItem
   |index=    MedMesh.i
   |clé=    Retreatment
}}
Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021